Source: Eur Respir J 2015; 45: 1197-1207



Rating:

Share or cite this content

Citations should be made in the following way:
Barnes Peter J., Bonini Sergio, Seeger Werner, Belvisi Maria G., Ward Brian, Holmes Anthony. Barriers to new drug development in respiratory disease. Eur Respir J 2015; 45: 1197-1207

Member's Comments

No comment yet.

Related content which might interest you: Delivering telemedicine interventions in chronic respiratory disease Source: Breathe 2014; 10: 198-212 Year: 2014 Alternative training strategies for patients with chronic respiratory disease Source: Eur Respir Monogr 2021; 93: 67-82 Year: 2021 Optimising disease models for lung diseases and drug development Source: International Congress 2015 – Development and application of new approaches for respiratory disease research Year: 2015 Home management of chronic respiratory disease through the use of telemedicine Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine Year: 2009 Reasons of non-adherence to telemonitoring programs in patients with chronic respiratory diseases. Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation Year: 2019 Self-management of respiratory disease Source: Respipedia Article Year: 2018 Rational use and stewardship of antibiotics in pediatric respiratory disease Source: ERS Courses: Paediatric respiratory infections Year: 2019 Strategy for early diagnosis and intervention in chronic respiratory disease Source: Virtual Congress 2020 – Chinese programme 2020: Part I Year: 2020 From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017 Improving adherence in paediatric respiratory disease Source: Breathe 2013; 9: 268-277 Year: 2013 Targeted therapy in respiratory disease Source: Breathe, 17 (4) 210170; 10.1183/20734735.0170-2021 Year: 2021 What are the knowledge gaps in COPD that prevent new drug development? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Exercise and respiratory health: improving disease consequences Source: International Congress 2019 – The future of respiratory diseases: what prevention can do Year: 2019 The use of technology to support integrated care of chronic respiratory disease Source: Annual Congress 2010 - Integrated care for chronic respiratory disease Year: 2010 Update on management of new emerging acute respiratory viral infectious diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 Auditing patterns of azithromycin use in respiratory disease Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011